OMDA Omada Health, Inc.
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.…
Industry Peers
Health Information ServicesKey Statistics
About Omada Health (NASDAQ: OMDA)
›
Omada Health (NASDAQ: OMDA) is listed on Nasdaq, where its shares trade in USD. It belongs to the Health Information Services industry, part of the Healthcare sector, and reports about 980 employees.
The shares were at 12.50 USD on 19 November 2026, down 34.2% over 52 weeks. Its 52-week range is 10.28 USD to 25.45 USD: the price is 50.9% below the high and 21.6% above the low.
At a market capitalisation of 775.47M USD, it trades at 31.3 times trailing earnings and 18.1 times forward earnings. The median trailing P/E of its 14 largest Health Information Services peers is 42.1, a discount of 26% for OMDA.
Omada Health reports return on equity of -5.6%, an operating margin of 2.1% and revenue up 34.2% year over year.
It holds more cash than debt, a net cash position of 243.15M USD. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 12 analysts cover the stock, with an average rating of Buy; their mean price target of 26.50 USD is 112.0% above the current price. The next earnings report is expected on 4 March 2027.